feed,title,long_url,short_url
Investors,Why Former Highflier Corcept Therapeutics Just Surged Again,https://www.investors.com/news/technology/corcept-therapeutics-ovarian-cancer-relacorilant/,
Investors,FCX Earnings Beat; 2026 Copper Sales Outlook Trimmed,https://www.investors.com/news/fcx-stock-q4-earnings-2026-copper-sales/,
Investors,Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing Looms,https://www.investors.com/news/technology/abbott-stock-abbott-laboratories-earnings-q4-2025-branch/,
